LONDON, Nov. 13, 2017 -- Global Biostimulants Market is expected to reach USD 3,040.3 million by 2022, supported by a CAGR of 12.7% during the forecast period of 2017 to 2022, according to a publication from Meticulous Research™. The global biostimulants market is mainly driven by the growing need to increase crop yield and quality, growing organic farming and demand for organic food, and wide range of benefits of biostimulants in crop production. Moreover, growing awareness about environmental safety with the use of biostimulants has further led the growth of biostimulants market globally. However, lack of education and awareness among farmers, and various challenges faced by new entrants and small players restrains the growth of biostimulants market. Also, unavailability of standardized regulatory framework for biostimulants and scientific & technical challenges for development of biostimulants challenges the growth of this market to some extent.
Geographically, Europe holds the major share in the global biostimulants market, followed by North America and Asia-Pacific region which is primarily attributed to the rising concern over harmful chemicals on environment, increasing demand for organic food, rapid development & innovation in biostimulants, and presence of large number of biostimulants providers. However, Asia-Pacific region possesses lucrative growth potential for the biostimulants market and is expected to witness a fastest growth during the forecast period. This is mainly attributed to its large area under agriculture cultivation, rising need to increase crop yield and quality with the growing population, increasing demand for organic foods, and various government initiatives to develop and increase application of biologicals in the region.
Request Sample Pages: http://www.meticulousresearch.com/request-sample-report/?cp_id=3140
The key players in the global biostimulants market are BASF SE, Valagro SpA, Biolchim S.p.A., Marrone Bio Innovation, Monsanto Company (Part of Bayer), Trade Corporation International (Part of Sapec Group), Plant Health Care PLC, Syngenta (Subsidiary of ChemChina), Biostadt India Limited, Andermatt Biocontrol AG, BioWorks, Inc., Novozymes, Inc., Koppert B.V., Italpollina S.p.A., Micromix Plant Health Ltd., Arysta LifeScience Corporation (Subsidiary of Platform Specialty Products Corporation), FMC Corporation, and Agrinos AS.
Browse Full Press Release: http://www.meticulousresearch.com/biostimulants-market-forecast/
Scope:
Market by Active Ingredients:
- Acid Based
- Humic Acid
- Amino Acid
- Fulvic Acid
- Extract Based
- Seaweed Extract
- Other Botanical Extracts
- Microbial Amendments
- Trace Minerals and Vitamins
- Others
Market by Mode of Application
- Foliar Spray
- Soil Treatment
- Seed Treatment
Market by Formulation:
- Solid
- Liquid
Market by Crop Type:
- Row Crops
- Fruits and Vegetables
- Turfs and Ornamentals
- Others
Browse in-Depth Report: http://www.meticulousresearch.com/product/biostimulants-market-2022/
Contact Info-
Viren Shrivastava
AVP- Global Sales and Marketing
Meticulous Research™
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 



